Aetna (AET) Tops Q3 EPS by 37c, Miss on Revenues; Offers FY17 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Aetna (AET) Tops Q3 EPS by 37c, Miss on Revenues; Offers FY17 EPS Guidance Above Consensus
November 1, 2017 8:51 AM EDT
Morgan Stanley raised its price target on Aetna (NYSE: AET) to $192.00 (from $179.00) while maintaining a Overweight rating following results.
...
More
November 1, 2017 8:00 AM EDT
Jefferies raised its price target on Aetna (NYSE: AET) to $185.00 (from $165.00) while maintaining a Hold rating.
Analyst David Windley listed 4 key insights from the quarter:
1. Strong, Well Balanced Results.
2. Repositioning or Dressing Up
3. Conservative MLR; We Are 2% > 2017 EPS Guidance.
4.... More
October 27, 2017 9:47 AM EDT
By Ankur Banerjee
(Reuters) - U.S. pharmacy operator CVS Health Corp's (NYSE: CVS) move to buy health insurer Aetna Inc (NYSE: AET) could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said.
Shares of Aetna, the third-largest U.S. health insurer, closed down 3 percent on Friday after closing 12 percent higher on Thursday on reports of the deal. CVS Health was down 5.9 percent.
CVS Health has made an offer to acquire... More
October 27, 2017 7:24 AM EDT
Guggenheim analyst, John Heinbockel, reiterated his Buy rating on shares of CVS Health (NYSE: CVS) after media reports state the company is is in talks to acquire Aetna (NYSE: AET) for more than $200 per share.... More
October 27, 2017 3:17 AM EDT
Cantor Fitzgerald downgraded Aetna (NYSE: AET) from Overweight to Neutral with a price target of $175.00.
Analyst Steven Halper cites speculation that CVS would buy the company for the downgrade noting the offer price is just above his PT and he believes the... More
